SMA 200 společnosti Shanghai Junshi Biosciences Co
Jaká je hodnota metriky SMA 200 společnosti Shanghai Junshi Biosciences Co?
Hodnota metriky SMA 200 společnosti Shanghai Junshi Biosciences Co., Ltd. je $2 -26.28%
Jaká je definice metriky SMA 200?
SMA 200 je průměrná cena akcií z posledních 200 dnů vypočítaná jako nevážený průměr předchozích 200 závěrečných cen.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 společností v sektoru Health Care sektor na OTC ve srovnání se společností Shanghai Junshi Biosciences Co
Čemu se věnuje společnost Shanghai Junshi Biosciences Co?
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclonal antibody under the trade name of TUOYI for the indication of melanoma, mucosal melanoma, soft tissue sarcoma, nasopharyngeal carcinoma, urothelial carcinoma, non-small cell lung carcinoma, triple negative breast carcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma. It is also developing UBP1211, a biosimilar of Humira for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriasis; JS002, a recombinant humanized anti-PCSK9 monoclonal antibody for treating hyperlipidemia; UBP1213, a recombinant humanized anti-BLyS monoclonal antibody for injection. In addition, the company is developing JS501, a biosimilar of Avastin; and JS003, a recombinant humanized anti-PD-L1 monoclonal antibody for injection; JS101, a pan-CDK inhibitor; TAB004/JS004, a recombinant humanized anti-BTLA monoclonal antibody for injection; and JS005, a recombinant humanized anti-IL-17A monoclonal antibody for injection. It has an agreement with Eli Lilly and Company to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus as well as Coherus Biosciences, Inc. for the development and commercialization of toripalimab, Junshi Biosciences' anti-PD-1 antibody. Shanghai Junshi Biosciences Co., Ltd. was founded in 2012 and is headquartered in Shanghai, People's Republic of China.
Firmy s metrikou sma 200 podobnou společnosti Shanghai Junshi Biosciences Co
- Hodnota metriky SMA 200 společnosti BSquare Corp je $2 +0.00%
- Hodnota metriky SMA 200 společnosti G Mining Ventures je CAD$2 -11.28%
- Hodnota metriky SMA 200 společnosti BD Multimedia SA je €2 -18.64%
- Hodnota metriky SMA 200 společnosti Roxgold je CAD$2 +0.39%
- Hodnota metriky SMA 200 společnosti INTERSHOP Communications Aktiengesellschaft je €2 -17.59%
- Hodnota metriky SMA 200 společnosti Regis Resources je AUD$2 -5.49%
- Hodnota metriky SMA 200 společnosti Shanghai Junshi Biosciences Co je $2 -26.28%
- Hodnota metriky SMA 200 společnosti BIOREM je CAD$2 +21.01%
- Hodnota metriky SMA 200 společnosti Nine Service Inc je $2 -73.94%
- Hodnota metriky SMA 200 společnosti Genesis Minerals je AUD$2 +11.80%
- Hodnota metriky SMA 200 společnosti Vincera Pharma je $2 -174.86%
- Hodnota metriky SMA 200 společnosti Giordano International je HKD$2 -24.03%
- Hodnota metriky SMA 200 společnosti Wah Fu Education Ltd je $2 -8.46%